Page 157 - 2017-2018 NSE FACTBOOK.cdr
P. 157

2017/2018 NSE FACT BOOK                                                                         2017/2018 NSE FACT BOOK
 The Performance Documentary of Listed Nigerian Companies                        The Performance Documentary of Listed Nigerian Companies






 MAIN BOARD                                                                                         MAIN BOARD
 FIDSON HEALTHCARE PLC  HEALTHCARE  GLAXOSMITHKLINE CONSUMER NIGERIA PLC                              HEALTHCARE



 HEAD OFFICE:  CONSOLIDATED STATEMENT OF FINANCIAL POSITION  HEAD OFFICE:  CONSOLIDATED STATEMENT OF FINANCIAL POSITION
 268, Ikorodu Road, Obanikoro, Lagos  GSK Nigeria House, 1 Industrial
 ---------------------------------------------------  Avenue Ilupeju, Lagos
 TELEPHONE:   2017  2016  2015  2014  2013  --------------------------------------------------   2017  2016  2015  2014  2013
 (+234) 01-3421902  N'000  N'000  N'000  N'000  N'000  TELEPHONE:   N'000     N'000    N'000     N'000    N'000
 ---------------------------------------------------  (+234) 1-3425131
 EMAIL:  Property, plant and equipment   12,363,213   12,206,210   11,501,335   10,790,758   7,043,474   --------------------------------------------------   Property, plant and equipment   2,311,992   2,761,731   13,874,242   13,419,394   12,121,857
 info@fidson.com  Intangibles   60,184    92,483    11,016.00    22,440    3,245   EMAIL:   Intangibles   -      -      -      -      -
 ---------------------------------------------------  Inventories    1,756,629    1,085,535    697,502    1,145,540    1,497,332   uchenna.a.uwechia@gsk.com  Inventories    3,368,426    4,440,834    7,418,238    7,589,550    5,616,340
 WEBSITE:   --------------------------------------------------
 www.fidson.com  Receivables    2,502,642    2,420,491    3,779,823    3,187,471    2,344,387   WEBSITE:   Receivables    7,505,112    5,771,241    6,398,910    5,287,412    4,557,811
 ---------------------------------------------------  Cash and bank balances    359,656    334,228    122,376    204,154    137,027   www.gsk.com.ng  Cash and bank balances    13,309,649    15,215,273    3,638,323    1,696,512    3,917,655
 ISSUED SHARE CAPITAL:  Total Assets    17,447,718    16,666,935    16,670,325    15,772,494    12,243,088   --------------------------------------------------   Total Assets    26,495,179    28,189,079    31,329,713    27,992,868    26,213,663
 750,000,000  ISSUED SHARE CAPITAL:                                      -
 ---------------------------------------------------  597,938,244
 DATE  OF INCORPORATION:           Current liabilities    7,088,742    6,642,906    6,646,548    5,909,026    4,070,893   --------------------------------------------------   Current liabilities    9,323,092    11,144,362    16,135,911    13,220,815    11,781,418
 13 March 1995  Non-current liabilities    2,736,056    3,430,763    3,699,949    4,098,187    2,926,860   DATE  OF INCORPORATION:           Non-current liabilities    -      302    2,008,588    1,823,809    2,086,531
 ---------------------------------------------------  Total Liabilities    9,824,798    10,073,669    10,346,497    10,007,213    6,997,753   23 June 1971  Total Liabilities    9,323,092    11,144,664    18,144,499    15,044,624    13,867,949
 DATE  LISTED ON THE EXCHANGE:      --------------------------------------------------
 5 June, 2008  Share capital    750,000    750,000    750,000    750,000    750,000   DATE  LISTED ON THE EXCHANGE:      Share capital    597,939    597,939    597,939    478,351    478,351
 ---------------------------------------------------  Share premium    2,973,043    2,973,043    2,973,043    2,973,043    2,973,043   1977  Share premium    51,395    51,395    51,395    51,395    51,395
 NSE SECTOR CLASSIFICATION:   Retained earnings    3,899,194    2,871,730    2,602,420    2,043,001    1,521,257   --------------------------------------------------   Retained earnings    16,522,753    16,395,081    12,535,880    12,418,498    11,815,968
 Pharmaceuticals  NSE SECTOR CLASSIFICATION:
 ---------------------------------------------------  Total Equity    7,622,920    6,593,266    6,323,828    5,765,281    5,245,335   Pharmaceuticals  Total Equity    17,172,087    17,044,415    13,185,214    12,948,244    12,345,714
 BOARD OF DIRECTORS:  Total Liabilities and Equity   17,447,718   16,666,935   16,670,325   15,772,494   12,243,088  --------------------------------------------------   Total Liabilities and Equity   26,495,179   28,189,079   31,329,713   27,992,868   26,213,663
 Mr. Felix O. A Ohiwerei    BOARD OF DIRECTORS:
 Dr. Fidelis A. Ayebae  Mr. Edmund .C. Onuzo
 Mr. Emmanuel E. Imoagene   Mr. Bhushan Akshikar
 Mrs. Olufunmilola O. Ayebae  Mr. Samuel Kuye
 Mrs Aishatu. P. Sadauki  Mr. Tunde Lemo OFR
 Ms. Mabel Ndagi  CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME  Mrs. Lubabatu Bello  CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME
 Mr. Olusegun S. Adebanji  Mr. Kareem Hamdy
 Mr. Olugbenga O. Olayeye  --------------------------------------------------
 Mr. Abiola A. Adebayo  COMPANY SECRETARY:
 ---------------------------------------------------  2017  2016  2015  2014  2013  Uchenna Uwechia  2017  2016  2015  2014  2013
 COMPANY SECRETARY:   N'000  N'000  N'000  N'000  N'000  Address: GSK House, 1 Industrial   N'000  N'000  N'000  N'000  N'000
 Mr. J. Abayomi Adebanjo FCIS  Revenue  14,057,394  7,655,029  8,210,000  9,719,185  9,235,056  Avenue Ilupeju, Lagos   Revenue  16,089,728  14,384,785  15,391,585  30,521,127  29,183,675
 Address: 268, Ikorodu Road Obanikoro,   Profit before tax  1,578,547  443,787  838,039  870,812  249,591  Email: uchenna.a.uwechia@gsk.com  Profit before tax  1,124,269  185,891  1,065,601  2,752,216  4,314,829
 Lagos      Telephone: (+234)7055200282
 Email: yomiadebanjo@fidson.com  Taxation    517,758    127,025    93,661    238,987    94,611   --------------------------------------------------   Taxation (expense)/credit   (637,836)   2,192,254    (192,467)   (903,374)   (1,395,659)
 Telephone: +234 08023146760 ,   Profit after tax   1,060,789  316,762  744,378  631,825  154,980  AUDITORS     Profit after tax   486,433  2,378,145  873,134  1,848,842  2,919,170
 08098140571  Transfer to revenue reserve   760,789  241,762  669,378  406,825  4,980  Deloitte  Transfer to revenue reserve   486,433  2,378,145  873,134  1,848,842  2,919,170
 ---------------------------------------------------  Address: Civic Centre Towers Plot GA
 AUDITORS   1, Ozumba Mbadiwe Avenue Victoria
 Ernst & Young (outgoing)  Profit attributable to:   Island Lagos  Profit attributable to:
 Address: 13th Floor UBA House,    Email: audenani@deloitte.com
 owners of the Company  1,060,789  316,762  744,378  631,825  154,980  owners of the Company  486,433  2,378,145  873,134  1,848,842  2,919,170
 Marina, Lagos Island.  Telephone: (+234)1-2717800
 Email: services@ng.ey.com  Non-controlling interest  --------------------------------------------------   Non-controlling interest   -      -      -      -      -
 Telephone: +234 01- 4630479-80  ,   COMPANY REGISTRARS:
 4630481  Earnings per 50k share [k]   71k  21k  50k  42k  10k  GTL Registrars Limited  Earnings per 50k share [k]   41   199    96    193    305
 ---------------------------------------------------  Net assets per 50k share [k]   508   440   422   384   350  Address:274, Murtala Muhammed   Net assets per 50k share [k]   14.36   14.25   11.03   27.06   25.81
 COMPANY REGISTRARS:   Way Yaba Lagos
 Meristem Registrars   Email: tcmadubueze@gtlregistrars
 Address: 213 Herbert Macaulay Way,   .com
 Adekunle Yaba.lagos  Telephone: (+234)1-2917747
 Email: info@meristemregistrars.com  --------------------------------------------------
 Telephone: (+234) 01-8920491  CAPITAL STRUCTURE:
 ---------------------------------------------------  Authorized: 1,500,000,000 Ordinary
 CAPITAL STRUCTURE:   Shares
 Authorized:  N1,200,000,000  Paid Up: 1, 195,876,488 Ordinary
 Paid Up: 750,000,000  Shares










 2017/2018 NSE FACTBOOK                                                                                               2017/2018 NSE FACTBOOK








 154                                                                                                                155
   152   153   154   155   156   157   158   159   160   161   162